UCB Biosciences, Inc.

ACTIVE

4000 Paramount Pkwy # 200, Morrisville, North Carolina, United StatesSubsidiary

Part of UCB, Inc.

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

37.9%

Phase 3

37.9%

Phase 1

13.8%

Trial Status Distribution

Available

3.5%

Completed

79.3%

Recruiting

3.5%

Terminated

13.8%

Clinical Trials

Trials sponsored by this organization (29)

A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome

Phase 3

Recruiting

interventional

Jul 2026200 participants

A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants

Phase 1

Completed

interventional

Dec 202422 participants

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome

Phase 3

Completed

interventional

May 202425 participants

An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency

Phase 2

Completed

interventional

Jul 201947 participants

Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.

Phase 2

Completed

interventional

May 2017103 participants

UCB Cimzia Pregnancy Follow-up Study

Terminated

observational

Nov 20161 participant

Open-label, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy Subjects

Phase 1

Completed

interventional

Mar 2016100 participants

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

Phase 3

Completed

interventional

Aug 2015239 participants

Page 1 of 4

Approvals

No approval data available

News

No news articles found

Back to Organizations